Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mycetomas are subcutaneous inflammatory pseudotumors containing fungal or actinomycetic (bacteria with branched filaments) granules or grains.
Biomarker and diagnostic research for mycetoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions and medical devices. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
204 publications have been identified in PubMed for mycetoma. Kisho has analyzed 72 by research type. Research spans Review / Meta-Analysis (53%), Case Report / Case Series (19%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 38 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 14 | 19% |
Disease patterns and progression | 11 | 15% |
Testing and diagnosis research | 3 | 4% |
Laboratory research | 2 | 3% |
New treatment approaches | 2 | 3% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Damián-Zapién A (2026). [PMID: 41417930](https://pubmed.ncbi.nlm.nih.gov/41417930/). *Rev Med Inst Mex Seguro Soc*. [Case Report / Case Series]
Anwar S (2026). [PMID: 42149907](https://pubmed.ncbi.nlm.nih.gov/42149907/). *PLoS Negl Trop Dis*. [Review / Meta-Analysis]
Saeed AA (2026). [PMID: 41671243](https://pubmed.ncbi.nlm.nih.gov/41671243/). *PLoS Negl Trop Dis*. [Review / Meta-Analysis]
Ahmed R (2026). [PMID: 41837668](https://pubmed.ncbi.nlm.nih.gov/41837668/). *Nanomedicine (London, England)*. [Review / Meta-Analysis]
Hoekstra M (2026). [PMID: 42139367](https://pubmed.ncbi.nlm.nih.gov/42139367/). *PLoS Negl Trop Dis*. [Review / Meta-Analysis]
Cataño JC (2026). [PMID: 42054682](https://pubmed.ncbi.nlm.nih.gov/42054682/). *N Engl J Med*. [Case Report / Case Series]
Ramos-Reza KY (2026). [PMID: 41128794](https://pubmed.ncbi.nlm.nih.gov/41128794/). *Eur J Clin Microbiol Infect Dis*. [Review / Meta-Analysis]
Chandler DJ (2026). [PMID: 41362932](https://pubmed.ncbi.nlm.nih.gov/41362932/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
Coimbra BZ (2025). [PMID: 39879491](https://pubmed.ncbi.nlm.nih.gov/39879491/). *Revista da Sociedade Brasileira de Medicina Tropical*. [Case Report / Case Series]
Keel B (2025). [PMID: 40775995](https://pubmed.ncbi.nlm.nih.gov/40775995/). *Studies in health technology and informatics*. [Diagnostic / Biomarker]